PT  - JOURNAL ARTICLE
ED  - ,
TI  - Thymoxamine (opilon)
AID  - 10.1136/dtb.7.25.99
DP  - 1969 Dec 05
TA  - Drug and Therapeutics Bulletin
PG  - 99--100
VI  - 7
IP  - 25
4099  - http://dtb.bmj.com/content/7/25/99.short
4100  - http://dtb.bmj.com/content/7/25/99.full
SO  - Drug Ther Bull1969 Dec 05; 7
AB  - Thymoxamine (Opilon-Warner) selectively blocks adrenergic α receptors. It is being promoted for ‘vasospastic or occlusive peripheral ischaemic conditions’, especially Raynaud’s syndrome, chilblains, Ménière’s syndrome, acrocyanosis, erythrocyanosis and excessively cold hands and feet.